Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study

2024

Safety and Efficacy of Prostatic Artery Embolization for Benign Prostatic Hyperplasia

Sample size: 140 publication 10 minutes Evidence: high

Author Information

Author(s): Pouchot Jules, Crombé Amandine, Burlet Luc, Farah Fadi, Baseilhac Pierre, David Arthur, Petitpierre François, Maaloum Rim, Le Bras Yann, Pagnoux Gaele, Derbel Haytham, Kobeiter Hicham, Barral Matthias, Frandon Julien, Marcelin Clément, Klein Clément, Jambon Eva, Yakar Derya

Primary Institution: Service de Radiologie et Imagerie Médicale de L’adulte, Centre Hospitalier Universitaire de Bordeaux

Hypothesis

This study aimed to evaluate the efficacy and safety of prostatic artery embolization (PAE) to remove indwelling urinary catheters in patients with symptomatic benign prostatic hyperplasia.

Conclusion

PAE is a safe and effective treatment option for elderly and inoperable patients with indwelling urinary catheters due to benign prostatic hyperplasia.

Supporting Evidence

80.7% of patients successfully had their catheters removed after PAE.
Only 2.1% of patients experienced major complications.
Post-PAE catheter-free survival rates were 87.5% at 6 months and 79% at 2 years.

Takeaway

Doctors can use a special procedure called prostatic artery embolization to help older men who have trouble urinating because of a swollen prostate, and it works well most of the time.

Methodology

This multicenter study included 140 men who underwent PAE for indwelling urinary catheters related to benign prostatic hyperplasia, with follow-up of at least 2 years.